Medicines
SmPC of the 02/07/2026
BEPANTHENE 250 mg/ml, solution for injection I.M.
Composition
Dexpanthenol (vitamin B5)...................................................................................................................250,0 mg
For 1 ml of injectable solution
Pantolactone, water for injections.
Dosage and administration
Dosage
Reserved for adults.
1 to 2 ampoules by I.M. injection 3 times per week for 6 weeks.
Method of administration
Intramuscular route.
Contraindications
• Hypersensitivity to the active substance or to any of the excipients listed in section Composition.
• Patients suffering from mechanical ileus.
Fertility, pregnancy and breastfeeding
Pregnancy
There is no reliable data on teratogenicity in animals.
In clinical practice, no particular malformative or foetotoxic effect has appeared to date. However, the follow-up of pregnancies exposed to this medicinal product is insufficient to exclude any risk.
Consequently, as a precautionary measure, it is preferable not to use this medicine during pregnancy.
Breast-feeding
In the absence of data, it is preferable not to use this medicine during breastfeeding.
Adverse effects
Undesirable effects are listed below by System Organ Class and by frequency. Frequencies are defined using the following classification: Very common (≥ 1/10); common (≥1/100; < 1/10); uncommon (≥1/1 000; <1/100); rare (≥ 1/10 000; <1/1 000); very rare (< 1/10 000), not known (cannot be estimated from the available data)
Immune system disorders
Very rare: Cutaneous allergic reactions of urticaria type, erythema, Quincke's oedema and bronchospasm
General disorders and administration site conditions
Frequency not known: reaction at the injection site
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: https://signalement.social-sante.gouv.fr/.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
1 RUE CLAUDE BERNARD
59000 LILLE
Tel: 03 28 16 34 00 Tel (toll-free): 08 00 87 54 54
https://www.bayer.fr
Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.